£114.89

This is the most expensive it has ever been. Walk away.

£115 today · previous high £115 · all-time low £90

Elsevier Developing Therapeutics for Alzheimer's Disease: Progress and Challenges

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 49 days · 49 data points (no recent data)

Historical
Generating forecast…
£114.89 £88.04 £93.90 £99.76 £105.61 £111.47 £117.33 25 July 2026 06 August 2026 18 August 2026 30 August 2026 11 September 2026
View at Amazon ↗

Price data last checked 42 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 49 days • 2 price levels

Days at Price
Current Price
3 days 46 days · current 0 12 23 35 46 £90 £115 Days at Price

Price Analysis

Most common price: £115 (46 days, 93.9%)

Price range: £90 - £115

Price levels: 2 different prices over 49 days

Description
Developing Therapeutics for Alzheimer's Disease: Progress and Challenges provides a thorough overview of the latest advances toward the development of therapeutics for Alzheimer's disease, along with the major hurdles that still must be overcome and potential solutions to these problems. Despite the lack of progress toward developing therapeutics that can slow or stop the progression of this disease, important discoveries have been made and many promising approaches are advancing in preclinical studies and clinical trials. This book outlines the special challenges related to specific targets and approaches, while presenting a realistic, comprehensive and balanced view of drug discovery and development in this area. Written by international leaders in the field, the book assesses prospects for the emergence of effective agents and allows readers to better understand the challenges, failures, and future potential for research in Alzheimer's disease. This book is a valuable resource to academic scientists carrying out translational research in Alzheimer's disease, industrial scientists engaged in Alzheimer's drug discovery, executives in biopharmaceutical companies making strategic decisions regarding the direction of internal research and potential outside partnerships, and graduate-level students pursuing courses on Alzheimer's therapeutics. * Provides a realistic but promising assessment of the potential of various therapeutic approaches to Alzheimer's disease* Focuses primarily on neuroprotective agents and cognitive enhancers, as well as approaches to targeting the amyloid B-peptide, tau and Apolipoprotein E* Discusses alternative approaches, preclinical and clinical development issues, related biomarkers and diagnostics, and prevention and nonpharmacological approaches

Product Specifications
Brand
Elsevier
Format
hardcover
ASIN
012802173X
Category
Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Neurology & Clinical Neurophysiology
Domain
Amazon UK
Release Date
01 June 2016
Listed Since
05 January 2016

Barcode

No barcode data available

Similar Products You Might Like

Springer - Pharmacological Mechanisms in Alzheimer's Therapeutics
97% match

Springer - Pharmacological Mechanisms in Alzheimer's Therapeutics

Springer

£83.20 18 Sep 2026
Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)
97% match

Alzheimer's Disease: Targets for New Clinical Diagnostic and Therapeutic Strategies (Frontiers in Neuroscience)

CRC Press

£122.62 24 Sep 2026
Neuroprotection in Alzheimer's Disease
97% match

Neuroprotection in Alzheimer's Disease

Elsevier

£90.99 25 Sep 2026
Alzheimer's Disease and Frontotemporal Dementia: Methods and Protocols: 670 (Methods in Molecular Biology, 670)
97% match

Alzheimer's Disease and Frontotemporal Dementia: Methods and Protocols: 670 (Methods in Molecular Biology, 670)

Humana

£84.82 24 Sep 2026
Pharmacological Treatment of Alzheimer's Disease: Molecular and Neurobiological Foundations
97% match

Pharmacological Treatment of Alzheimer's Disease: Molecular and Neurobiological Foundations

Wiley

£154.94 04 Sep 2026
A New Era in Alzheimer's Research: Pathogenesis, Prevention, and Treatment
97% match

A New Era in Alzheimer's Research: Pathogenesis, Prevention, and Treatment

Elsevier

£111.99 26 Aug 2026
Research Progress in Alzheimer's Disease & Dementia: v. 4 (Research Progress in Alzheimer's Disease and Dementia): Volume 4
97% match

Research Progress in Alzheimer's Disease & Dementia: v. 4 (Research Progress in Alzheimer's Disease and Dementia): Volume 4

£12.97 18 Sep 2026
Biomarkers for Preclinical Alzheimer’s Disease: 137 (Neuromethods, 137)
97% match

Biomarkers for Preclinical Alzheimer’s Disease: 137 (Neuromethods, 137)

Humana

£69.07 12 Sep 2026
Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease
97% match

Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease

Elsevier

£91.28 11 Sep 2026
Biomarkers for Early Diagnosis of Alzheimer's Disease
96% match

Biomarkers for Early Diagnosis of Alzheimer's Disease

£58.28 25 Sep 2026
Nutraceuticals for Alzheimer's Disease: A Promising Therapeutic Approach (Nutritional Neurosciences)
96% match

Nutraceuticals for Alzheimer's Disease: A Promising Therapeutic Approach (Nutritional Neurosciences)

Springer

£126.45 08 Sep 2026
Alzheimer's Disease Drug Development: Research and Development Ecosystem
96% match

Alzheimer's Disease Drug Development: Research and Development Ecosystem

Cambridge University Press

£45.44 28 Aug 2026
The End of Alzheimer's: The Brain and Beyond
96% match

The End of Alzheimer's: The Brain and Beyond

Elsevier

£50.89 21 Sep 2026
Biomarkers for Alzheimer’s Disease Drug Development: 1750 (Methods in Molecular Biology, 1750)
96% match

Biomarkers for Alzheimer’s Disease Drug Development: 1750 (Methods in Molecular Biology, 1750)

Humana

£81.54 30 Sep 2026
Molecular Targets in Protein Misfolding and Neurodegenerative Disease: Focus on Tau, Alzheimer's Disease, and Other Tauopathies
96% match

Molecular Targets in Protein Misfolding and Neurodegenerative Disease: Focus on Tau, Alzheimer's Disease, and Other Tauopathies

Elsevier

£74.59 06 Sep 2026
Practical Pharmacology for Alzheimer’s Disease
96% match

Practical Pharmacology for Alzheimer’s Disease

Springer

£143.62 01 Oct 2026
Practical Pharmacology for Alzheimer’s Disease
96% match

Practical Pharmacology for Alzheimer’s Disease

Springer

£76.51 01 Oct 2026
ALZHEIMER'S DISEASE: INSIGHTS INTO LOW MOLECULAR WEIGHT AND CYTOTOXIC AGGREGATES FROM IN VITRO AND COMPUTER EXPERIMENTS - MOLECULAR BASIS OF ... (MOLECULAR MEDICINE AND MEDICINAL CHEMISTRY)
96% match

ALZHEIMER'S DISEASE: INSIGHTS INTO LOW MOLECULAR WEIGHT AND CYTOTOXIC AGGREGATES FROM IN VITRO AND COMPUTER EXPERIMENTS - MOLECULAR BASIS OF ... (MOLECULAR MEDICINE AND MEDICINAL CHEMISTRY)

Imperial College Press

£77.60 08 Sep 2026
Early Detection of Alzheimer’s Disease: Biological and Technological Advances
96% match

Early Detection of Alzheimer’s Disease: Biological and Technological Advances

Elsevier

£106.38 25 Sep 2026